Investor Relations

To sign up to receive Investor News as it is released please email Walbrook PR

06/06/18	FINAL RESULTS FOR THE YEAR ENDED 31 MARCH 2018
06/08/18	VISITECT® CD4 Advanced Disease Development Update
18/07/18	VISITECT® CD4 commercialisation update
02/07/18	Notice of Results - RNS
28/06/18	Disposal of Infectious Disease Business
21/05/18	VISITECT CD4 Update
08/05/18	Allersys CE Mark
02/05/18	Closure of Omega Diagnostics GmbH
24/04/18	PDRM Dealing
24/04/18	Holding(s) in Company
23/04/18	Holding(s) in Company
23/04/18	Director/PDMR Shareholding
23/04/18	Holding(s) in Company
23/04/18	Director/PDMR Shareholding
20/04/18	Allersys Distributon Agreement
10/04/18	Strategic Review of Operations and Trading Update
10/04/18	Price Monitoring Extension
12/01/18	Holding(s) in Company
21/12/17	Allersys® CE-Mark
14/12/17	CEO Succession
29/11/17	VISITECT^® CD4 CE-Mark
01/11/17	Change of Registered Address
23/10/17	T rading Update and Notice of Interim Results
16/10/17	US Supply Agreement
10/10/17	Holding(s) in Company
05/09/17	Exercise of Options and Total Voting Rights
29/08/17	Result of AGM
18/07/17	Result of General Meeting
17/07/17	Result of Open Offer
06/07/17	Sale and leaseback of the building owned by Omega GmbH
30/06/17	Result of Proposed Fundraising
30/06/17	Proposed Fundraising
30/06/17	Final Results - FY17
25/04/17	Trading Update and Notice of Results
21/04/17	Holding(s) in Company
29/03/17	VISITECT® Malaria CE-Mark and successful Indian FDA inspection
07/03/17	Holding(s) in Company
27/02/17	Holding(s) in Company
22/01/17	Update on discussions with Immunodiagnostic Systems Holdings plc
11/01/17	ISO accreditation for manufacturing facility in Pune, India
24/11/16	Holding(s) in Company
17/10/16	Trading Update and Notice of Interim Results
10/08/16	Result of AGM
02/08/16	R&D Grant Funding
04/07/16	Holding(s) in Company
01/07/16	Holding(s) in Company
27/06/16	Final Results - FY16
09/06/16	Holding(s) in Company
21/04/16	Trading Update and Notice of Results
08/02/16	Holding(s) in Company